Cargando…
Docetaxel-loaded solid lipid nanoparticles suppress breast cancer cells growth with reduced myelosuppression toxicity
Docetaxel is an adjuvant chemotherapy drug widely used to treat multiple solid tumors; however, its toxicity and side effects limit its clinical efficacy. Herein, docetaxel-loaded solid lipid nanoparticles (DSNs) were developed to reduce systemic toxicity of docetaxel while still keeping its antican...
Autores principales: | Yuan, Qing, Han, Jing, Cong, Wenshu, Ge, Ying, Ma, Dandan, Dai, Zhaoxia, Li, Yaping, Bi, Xiaolin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4207579/ https://www.ncbi.nlm.nih.gov/pubmed/25378924 http://dx.doi.org/10.2147/IJN.S70919 |
Ejemplares similares
-
Docetaxel-Loaded Solid Lipid Nanoparticles Suppress Breast Cancer Cells Growth with Reduced Myelosuppression Toxicity [Erratum]
Publicado: (2019) -
Docetaxel-loaded solid lipid nanoparticles as a basis for a targeted and dose-sparing personalized breast cancer treatment strategy
por: Danilova, Natalia V, et al.
Publicado: (2015) -
Docetaxel-loaded solid lipid nanoparticles prevent tumor growth and lung metastasis of 4T1 murine mammary carcinoma cells
por: da Rocha, Márcia Cristina Oliveira, et al.
Publicado: (2020) -
Acute toxicity study of tilmicosin-loaded hydrogenated castor oil-solid lipid nanoparticles
por: Xie, Shuyu, et al.
Publicado: (2011) -
Functionalized docetaxel-loaded lipid-based-nanosuspensions to enhance antitumor efficacy in vivo
por: Pang, Xiuping, et al.
Publicado: (2019)